All Stories

  1. Longitudinal hemodynamic evaluation of uncomplicated twin pregnancies according to chorionicity: physiological cardiovascular dysfunction in monochorionic twin pregnancy
  2. The cardiac-fetal-placental unit: fetal umbilical vein flow rate is linked to the maternal cardiac profile in fetal growth restriction
  3. Maternal hemodynamics for the identification of early fetal growth restriction in normotensive pregnancies
  4. Hemodynamic assessment in patients with preterm premature rupture of the membranes (pPROM)
  5. Systemic vascular resistance may influence the outcome of in vitro fertilization
  6. Maternal peripheral vascular resistance at mid gestation in chronic hypertension as a predictor of fetal growth restriction
  7. Distinction between SGA and FGR by means of fetal umbilical vein flow and maternal hemodynamics
  8. Fetal Umbilical Vein Flow in the Classification of Fetuses with Growth Restriction
  9. Hemodynamic maladaptation and left ventricular dysfunction in chronic hypertensive patients at the beginning of gestation and pregnancy complications: a case control study
  10. Pregnancy complications in chronic hypertensive patients are linked to pre-pregnancy maternal cardiac function and structure
  11. Hemodynamic guided treatment of hypertensive disorders in pregnancy: is it time to change our mind?
  12. Friendly help for clinical use of maternal hemodynamics
  13. OC10.05: The “Valensise Radar” to understand the maternal hemodynamic status
  14. Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics
  15. Prevention and Treatment of Fetal Growth Restriction by Influencing Maternal Hemodynamics and Blood Volume
  16. Hemodynamic Prediction and Stratification of Hypertensive Disorders of Pregnancy: A Dream That Is Coming True?
  17. Assessment of venous hemodynamics and volume homeostasis during pregnancy: recommendations of the International Working Group on Maternal Hemodynamics
  18. Restricted physical activity in pregnancy reduces maternal vascular resistance and improves fetal growth
  19. Maternal hemodynamics early in labor: a possible link with obstetric risk?
  20. Functional testing in pregnancy
  21. Screening for pre‐eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non‐obese patients
  22. Correlation between maternal body composition and haemodynamic changes in pregnancy: different profiles for different hypertensive disorders
  23. Assessment of arterial function in pregnancy: recommendations of the International Working Group on Maternal Hemodynamics
  24. Preterm delivery and elevated maternal total vascular resistance: signs of suboptimal cardiovascular adaptation to pregnancy?
  25. A5. Bed rest reduces maternal total vascular resistance and enhances fetal growth
  26. D2. Screening of preeclampsia (PE) in the first trimester: high total vascular resistance (TVR) with a reduced fat mass increase the risk in normo BMI patients
  27. F1. Is there a correlation between total body water distribution and haemodynamic changes during pregnancy?
  28. G1. Maternal haemodynamics assessment in preterm delivery: two different haemodynamic profiles
  29. G2. Low pregestational fat mass and subsequent maternal cardiovascular maladaptation in early pregnancy. The missing link for preeclampsia
  30. H1. Persistent maternal cardiac dysfunction after preeclampsia identifies patients at risk for recurrent pre-eclampsia
  31. Persistent Maternal Cardiac Dysfunction After Preeclampsia Identifies Patients at Risk for Recurrent Preeclampsia
  32. Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy. A key for the prevention of preeclampsia
  33. PRE-ECLAMPSIA: ONE NAME, TWO CONDITIONS – THE CASE FOR EARLY AND LATE DISEASE BEING DIFFERENT
  34. Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications
  35. Left ventricular midwall mechanics at 24 weeks' gestation in high-risk normotensive pregnant women: relationship to placenta-related complications of pregnancy
  36. OC14.06: NO donors and volume expansion added to antihypertensive therapy in gestational hypertension decreases systemic vascular resistance and complications
  37. Early and Late Preeclampsia
  38. OP11.10: Maternal myocardial function in asymptomatic 24 weeks' bilateral notching women
  39. Total Vascular Resistance and Left Ventricular Morphology as Screening Tools for Complications in Pregnancy
  40. Fetal growth restriction and maternal cardiac function
  41. OC216: Treatment with NO donor patches in asymptomatic women with bilateral notch and elevated total vascular resistance
  42. Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery
  43. Maternal total vascular resistance and concentric geometry: a key to identify uncomplicated gestational hypertension
  44. P10.19: Intrauterine growth restriction and fetal body composition
  45. P10.05: Nitric oxide donors and fluid therapy increase fetal growth in gestational hypertension
  46. Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome
  47. P05.28: Can we improve fetal growth acting on maternal cardiac function? A pilot study
  48. Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restriction
  49. Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies
  50. MATERNAL CARDIOVASCULAR HAEMODYNAMICS IN NORMAL AND COMPLICATED PREGNANCIES
  51. Maternal cardiac systolic function and total body water estimation in normal and gestational hypertensive women
  52. Left Ventricular Concentric Geometry as a Risk Factor in Gestational Hypertension
  53. Nifedipine-induced changes in body composition in hypertensive patients at term
  54. Are Gestational and Essential Hypertension Similar? Left Ventricular Geometry and Diastolic Function
  55. P217: Does nifedipine improve placental function and fetal growth?
  56. Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction
  57. C-peptide and insulin levels at 24–30 weeks’ gestation: an increased risk of adverse pregnancy outcomes?
  58. Maternal diastolic function in asymptomatic pregnant women with bilateral notching of the uterine artery waveform at 24 weeks' gestation: a pilot study
  59. Maternal Diastolic Dysfunction and Left Ventricular Geometry in Gestational Hypertension
  60. WS12-03Uteroplacental resistances and maternal cardiac function in normal and hypertensive pregnancy: a Doppler and echocardiographic study
  61. Maternal cardiac systolic and diastolic function: relationship with uteroplacental resistances. A Doppler and echocardiographic longitudinal study
  62. Cardiac Function
  63. Cardiac Dysfunction in Hypertensive Pregnancy